You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice
Active, not recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, Mantle-Cell
  • Paris Cedex 13, France
    (unnamed)
2022-03-24
Mar 24, 2022
S
Phase I Study of JWCAR029 in Subjects With R/R CLL/SLL
Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • JWCAR029 (Relmacabtagene Autoleucel)
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
2022-02-17
Feb 17, 2022
M
Family Study of Lymphoproliferative Disorders
Recruiting
  • Lymphoma, Non-Hodgkin
  • +4 more
    • Rochester, Minnesota
      Mayo Clinic
    2021-08-30
    Aug 30, 2021
    U
    Determination of Blood Tumor Cells
    Recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Abnormalities Cell Epithelial
      • Zurich, Switzerland
        University Hospital Zurich
      2021-10-05
      Oct 5, 2021
      C
      Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma
      Recruiting
      • Leukemia
      • +3 more
      • CD19 CAR-T cells
      • Chongqing, Chongqing, China
        Chongqing University Cancer Hospital
      2021-03-01
      Mar 1, 2021
      H
      CD19/CD20 Dual-CAR-T in B-cell Leukemia Patients - 2022
      Completed
      • B-cell Leukemia
      • CD19/CD20 Dual-CAR-T cells
      • Sanhe, Hebei, China
        Hebei Yanda Ludaopei Hospital
      2022-03-06
      Mar 6, 2022
      C
      CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma
      Recruiting
      • Leukemia
      • +4 more
      • CD19 CAR-T cells
      • Kunming, Yunnan, China
        920th Hospital of Joint Logistics Support Force
      2021-03-01
      Mar 1, 2021
      U
      In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)
      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • [U-13C]glucose
      • [13C5]glutamine
      • (no location specified)
      2022-03-18
      Mar 18, 2022
      A
      Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL) - 2012
      Completed
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Innsbruck, Tirol, Austria
      • +6 more
      2022-02-15
      Feb 15, 2022
      T
      Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL) - 2010
      Completed
      • CLL
        • Tampere, Finland
          Tampere university Hospital
        2022-02-22
        Feb 22, 2022
        D
        Understanding Chronic Lymphocytic Leukemia
        Recruiting
        • Chronic Lymphocytic Leukemia
          • Boston, Massachusetts
            Dana Farber Cancer Institute
          2021-07-14
          Jul 14, 2021
          N
          Pharmacokinetics of Venetoclax in Patients With Chronic Lymphocytic Leukemia
          Recruiting
          • Chronic Lymphocytic Leukemia
          • Taipei, Taiwan
            National Taiwan University Hospital
          2021-10-27
          Oct 27, 2021
          N
          Molecular Features Underlying Racial Differences in Survival of Taiwanese Chronic Lymphocytic Leukemia Patients - 2021
          Completed
          • Chronic Lymphocytic Leukemia (CLL)
            • (no location specified)
            2022-04-05
            Apr 5, 2022
            L
            A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
            Not yet recruiting
            • Chronic Lymphocytic Leukemia
            • +3 more
            • (no location specified)
            2022-02-15
            Feb 15, 2022
            U
            CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy - 2021
            Completed
            • B-cell Leukemia
            • B-Cell Lymphoma
            • CAR T cells
            • Uppsala, Sweden
              Uppsala University Hospital, Dept of Oncology
            2021-10-14
            Oct 14, 2021
            M
            CAR20.19.22 T-cells in Relapsed, Refractory B-cell Malignancies
            Not yet recruiting
            • B-cell Non Hodgkin Lymphoma
            • B-cell Chronic Lymphocytic Leukemia
            • Dose Level -1: 0.75x10^6 cells/kg CAR20.19.22 cells
            • +3 more
            • Milwaukee, Wisconsin
              Medical College of Wisconsin and Froedtert Hospital
            2022-03-30
            Mar 30, 2022
            N
            Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - 2021
            Terminated
            Has Results
            • Small Lymphocytic Leukemia (SLL)
            • Chronic Lymphocytic Leukemia (CLL)
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            2022-02-15
            Feb 15, 2022
            N
            Characterization of Proliferating Compartment in B-Cell Patients and in Healthy Aging Subjects - 2016
            Completed
            • Chronic Lymphocytic Leukemia
              • Manhasset, New York
                Feinstein Institute for Medical Research
              2021-03-02
              Mar 2, 2021
              W
              ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma
              Active, not recruiting
              • Leukemia
              • Lymphoma
              • ET019003-T Cells
              • Wuhan, Hubei, China
                Union Hospital, Tongji Medical College, Huazhong University of S
              2021-11-11
              Nov 11, 2021
              A
              Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Kazakh Nationality
              Not yet recruiting
              • B Cell Leukemia
              • Lymphoma
              • SNP analysis of the DNA
              • (no location specified)
              2021-10-26
              Oct 26, 2021
              M
              Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL) - 2022
              Completed
              • CLL
              • Leukemia
              • Houston, Texas
                University of Texas MD Anderson Cancer Center
              2022-03-14
              Mar 14, 2022
              U
              Belimumab in Patients With Chronic Lymphocytic Leukemia
              Recruiting
              • Chronic Lymphoid Leukemia in Relapse
              • Belimumab 200 MG/ML [Benlysta]
              • standard of care
              • Tuebingen, BW, Germany
                University Hospital Tuebingen, CCU Translational Immunology
              2022-02-02
              Feb 2, 2022
              E
              Study of Oral LOXO-338 in Patients With Advanced Blood Cancers
              Recruiting
              • Leukemia, Lymphocytic, Chronic, B-Cell
              • +6 more
              • Miami, Florida
              • +4 more
              2022-03-07
              Mar 7, 2022
              M
              Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic Leukemia
              Active, not recruiting
              • Chronic Lymphocytic Leukemia
              • Questionnaire Administration
              • Ruxolitinib Phosphate
              • Houston, Texas
                M D Anderson Cancer Center
              2022-02-02
              Feb 2, 2022
              E
              Intermittent Fasting and CLL/SLL
              Active, not recruiting
              • Neoplasms
              • +5 more
              • Intermittent fast
              • Victoria, British Columbia, Canada
                Eleah Stringer
              2022-03-15
              Mar 15, 2022